» Articles » PMID: 32982210

Enjoying Breathing Program: A National Prospective Study Protocol to Improve Chronic Obstructive Pulmonary Disease Management in Chinese Primary Health Care

Overview
Publisher Dove Medical Press
Specialty Pulmonary Medicine
Date 2020 Sep 28
PMID 32982210
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chronic obstructive pulmonary disease (COPD) is prevalent and poses a heavy burden worldwide. However, patients know little about COPD, and primary health care providers have poor therapy capability in China. Enjoying Breathing Program aims to establish a new comprehensive COPD patient management system, including early detection, standardized therapy, and follow-up in China. The goal of the study is to 1) describe the intervention for physicians and patients and 2) to assess the effectiveness of this program.

Methods: It is the first nationwide trial involving all levels of health care institutions from primary health care institutions to tertiary hospitals. It includes a series of structured but individualized intervention for both health care providers and COPD patients. Primary health care providers from pilot hospitals will take both online and face-to-face courses, including the procedure of COPD patients' management and prevention, diagnosis and treatment. Once the patients are diagnosed with COPD, they will undertake standard therapy and self-management education program, perform rehabilitation exercises, and be followed up by primary health care providers every 3 months. The primary outcome will be exacerbation-related hospital/emergency admission and the change of patients' awareness and primary health care providers' knowledge of COPD within 36 months. Secondary outcome will include the change of pulmonary function test, structured COPD patients' management, two-way referral, and standardized therapy.

Conclusion: A comprehensive COPD patient management model to promote the standardized therapy will be established; this will improve COPD patients' awareness and health quality.

Trial Registration Number: This study has been registered at www.ClinicalTrials.gov (registration identifier: NCT04318912).

Citing Articles

Comparison of STAR and GOLD in Assessing Disease Severity Among High-Risk and COPD Patients: Evidence from Enjoying Breathing Program in China.

Huang K, Tang X, Chu X, Niu H, Li W, Zheng Z Int J Chron Obstruct Pulmon Dis. 2025; 19:2751-2762.

PMID: 39741665 PMC: 11687320. DOI: 10.2147/COPD.S492178.


Effectiveness and cost-effectiveness of an integrated digital psychological intervention () in Chinese chronic obstructive pulmonary disease patients: Study protocol of a randomized controlled trial.

Chen S, Chen W, Li Y, Yu Y, Chen Q, Jiao L Digit Health. 2024; 10:20552076241277650.

PMID: 39381816 PMC: 11459470. DOI: 10.1177/20552076241277650.


The care cascade of chronic obstructive pulmonary disease in China: a cross-sectional study of individual-level data at enrolment into the national 'Happy Breathing' Programme.

Wang C, Qi W, Yang T, Jiao L, Chen Q, Huang K EClinicalMedicine. 2024; 74:102597.

PMID: 39114273 PMC: 11305216. DOI: 10.1016/j.eclinm.2024.102597.


Cost-effectiveness of population-based screening for chronic obstructive pulmonary disease in China: a simulation modeling study.

Chen Q, Fan Y, Huang K, Li W, Geldsetzer P, Barnighausen T Lancet Reg Health West Pac. 2024; 46:101065.

PMID: 38721063 PMC: 11077022. DOI: 10.1016/j.lanwpc.2024.101065.


Sociodemographic correlates with prevalence of comorbidities in patients with chronic obstructive pulmonary disease: a study from a Chinese National Survey.

Huang K, Zheng Z, Li W, Niu H, Lei J, Dong F Lancet Reg Health West Pac. 2024; 42:100937.

PMID: 38357399 PMC: 10865049. DOI: 10.1016/j.lanwpc.2023.100937.


References
1.
Mannino D, Buist A . Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007; 370(9589):765-73. DOI: 10.1016/S0140-6736(07)61380-4. View

2.
Zhou Y, Chen S, Tian J, Cui J, Li X, Hong W . Development and validation of a chronic obstructive pulmonary disease screening questionnaire in China. Int J Tuberc Lung Dis. 2013; 17(12):1645-51. DOI: 10.5588/ijtld.12.0995. View

3.
. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053):1545-1602. PMC: 5055577. DOI: 10.1016/S0140-6736(16)31678-6. View

4.
Janssen M, Pickard A, Golicki D, Gudex C, Niewada M, Scalone L . Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2012; 22(7):1717-27. PMC: 3764313. DOI: 10.1007/s11136-012-0322-4. View

5.
Korpershoek Y, Bruins Slot J, Effing T, Schuurmans M, Trappenburg J . Self-management behaviors to reduce exacerbation impact in COPD patients: a Delphi study. Int J Chron Obstruct Pulmon Dis. 2017; 12:2735-2746. PMC: 5608232. DOI: 10.2147/COPD.S138867. View